Conference Coverage

Bloating. Flatulence. Think SIBO


 

EXPERT ANALYSIS FROM RWCS 2018

Indeed, 40% of patients will experience recurrent SIBO symptoms within 9 months after a round of rifaximin. Recurrences are more common in patients on chronic proton pump–inhibitor therapy, the elderly, and those who have undergone appendectomy. Such patients may need another course of rifaximin once or twice per year.

“If they need rifaximin every 6 months, fine. Patients will be so grateful to you for that course of rifaximin,” Dr. Mahadevan said.

Patients with methane-predominant bacterial overgrowth, as opposed to hydrogen-predominant overgrowth, often benefit from concomitant neomycin at 500 mg twice per day along with their 10-14 days of rifaximin.

“A lot of our cirrhotic patients are on both,” she noted.

Pages

Recommended Reading

AGA Guideline: Use goal-directed fluid therapy, early oral feeding in acute pancreatitis
MDedge Internal Medicine
VIDEO: No short-term link found between PPIs, myocardial infarction
MDedge Internal Medicine
Ulcerative colitis is disabling over time
MDedge Internal Medicine
National Early Warning Score discriminates deterioration of inpatients with liver disease
MDedge Internal Medicine
Expert shares tips for positioning biologics in IBD patient treatment
MDedge Internal Medicine
Colorectal cancer deaths projected for 2018
MDedge Internal Medicine
New C. difficile guidelines recommend fecal microbiota transplants
MDedge Internal Medicine
Mortality estimates put pancreatic cancer on the map
MDedge Internal Medicine
Guidelines update best practices for hemorrhoid treatment
MDedge Internal Medicine
NASH rapidly overtaking hepatitis C as cause of liver cancer
MDedge Internal Medicine